NEW YORK, March 29, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) between October 31, 2022, and August 2, 2024, both dates...
Hence then, the article about atnm investors have opportunity to lead rosen nationally regarded investor counsel encourages actinium pharmaceuticals inc securities fraud lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ATNM Investors Have Opportunity to Lead ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Actinium Pharmaceuticals, Inc. Securities Fraud Lawsuit )
Also on site :
- Danielle Deadwyler, Ella Beatty, Ike Barinholtz, Connor Storrie & More Confirmed For Focus Features’ ‘The Bell Jar’ As Production Wraps
- 9 Years Ago, a Stephen King Adaptation Became the Highest-Grossing Horror Movie Ever — And Still Holds the Title
- Woman seriously injured in Tenderloin dog attack Tuesday morning